HomeInsightsStock Comparison

Alembic Pharmaceuticals Ltd vs Alkem Laboratories Ltd Stock Comparison

Alembic Pharmaceuticals Ltd vs Alkem Laboratories Ltd Stock Comparison

Last Updated on: Dec 18, 2025

Key Highlights

  • The Latest Trading Price of Alembic Pharmaceuticals Ltd is ₹ 848.9 as of 18 Dec 15:30.
  • The P/E Ratio of Alembic Pharmaceuticals Ltd changed from 12.1 on March 2020 to 31.3 on March 2025 . This represents a CAGR of 17.16% over 6 yearsThe P/E Ratio of Alkem Laboratories Ltd changed from 24.7 on March 2020 to 26.9 on March 2025 . This represents a CAGR of 1.43% over 6 years.
  • The Market Cap of Alembic Pharmaceuticals Ltd changed from ₹ 10059 crore on March 2020 to ₹ 18265 crore on March 2025 . This represents a CAGR of 10.45% over 6 yearsThe Market Cap of Alkem Laboratories Ltd changed from ₹ 27844 crore on March 2020 to ₹ 58347 crore on March 2025 . This represents a CAGR of 13.12% over 6 years.
  • The revenue of Alembic Pharmaceuticals Ltd for the Sep '25 is ₹ 1918 crore as compare to the Jun '25 revenue of ₹ 1717 crore. This represent the growth of 11.72% The revenue of Alkem Laboratories Ltd for the Sep '25 is ₹ 4104 crore as compare to the Jun '25 revenue of ₹ 3520 crore. This represent the growth of 16.59%.
  • The ebitda of Alembic Pharmaceuticals Ltd for the Sep '25 is ₹ 324.02 crore as compare to the Jun '25 ebitda of ₹ 287.4 crore. This represent the growth of 12.74% The ebitda of Alkem Laboratories Ltd for the Sep '25 is ₹ 1024 crore as compare to the Jun '25 ebitda of ₹ 888.47 crore. This represent the growth of 15.31%.
  • The net profit of Alembic Pharmaceuticals Ltd changed from ₹ 120.6 crore to ₹ 183.71 crore over 10 quarters. This represents a CAGR of 18.34% The net profit of Alkem Laboratories Ltd changed from ₹ 287.81 crore to ₹ 779.6 crore over 10 quarters. This represents a CAGR of 48.97% .
  • The Dividend Payout of Alembic Pharmaceuticals Ltd changed from 19.45 % on March 2020 to 42.97 % on March 2025 . This represents a CAGR of 14.12% over 6 yearsThe Dividend Payout of Alkem Laboratories Ltd changed from 23.64 % on March 2020 to 23.59 % on March 2025 . This represents a CAGR of -0.04% over 6 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Alembic Pharmaceuticals Ltd

  • Alembic Pharmaceuticals Limited manufactures and markets generic pharmaceutical products all over the world.
  • The company's state of the art research and manufacturing facilities are approved by regulatory authorities of many developed countries including the US FDA. The company is one of the leaders in branded generics in India. Alembic Pharmaceuticals Limited was incorporated on June 16, 2010 as a wholly owned subsidiary of Alembic Limited.
  • The company is engaged in pharmaceuticals business.
  • As per the Scheme of Arrangement, the 'Pharmaceutical Undertaking' of Alembic Limited got demerged and transferred to the Company with effect from April 1, 2010. In April 2011, the company ceased to be a subsidiary of Alembic Ltd consequent to the allotment of 13,35,15,914 equity shares of Rs 2 each to the shareholders of Alembic Ltd as per the scheme of arrangement.

About Alkem Laboratories Ltd

  • Headquartered in Mumbai, India, Alkem Laboratories Limited is a leading Indian pharmaceutical company with global operations.
  • The company is engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products.
  • The company produces branded generics, generic drugs, active pharmaceutical ingredients (APIs) and nutraceuticals, which it markets in India and international markets.
  • With a portfolio of more than 800 brands in India, Alkem is ranked the fifth largest pharmaceutical company in India in terms of domestic sales.
  • The company also has presence in more than 40 international markets, with the United States being its key focus market. Alkem Laboratories Limited was incorporated as a private limited company on August 8, 1973 in Patna and subsequently became a deemed public limited company on October 26, 1988.

Alembic Pharmaceuticals Ltd News Hub

News

Alembic Pharma receives USFDA approval for Travoprost ophthalmic solution

The approved ANDA is therapeutically equivalent to the reference listed drug (RLD), Travat...

Read more

18 Dec 2025 12:41

News

Alembic receives USFDA approval for Travoprost Ophthalmic Solution

Alembic Pharmaceuticals (Alembic) today announced that it has received final approval from...

Read more

18 Dec 2025 16:44

News

Alembic receives USFDA approval for Loteprednol Etabonate and Tobramycin Ophthalmic Suspension 0.5%/0.3%

Alembic Pharmaceuticals (Alembic) today announced that it has received final approval from...

Read more

11 Dec 2025 15:09

News

Alembic Pharmaceuticals announces change in senior management

Alembic Pharmaceuticals announced that Prashant Khandelwal, Head-International Business Fo...

Read more

01 Dec 2025 19:10

News

Alembic Pharma gains after generic gets USFDA nod

The approval covers strengths of 30 mg, 60 mg, 90 mg and 120 mg. The product is the generi...

Read more

17 Nov 2025 11:54

News

Alembic Pharma gets US FDA approval for angina treatment drug Diltiazem

The approved ANDA is therapeutically equivalent to the reference listed drug (RLD), Cardiz...

Read more

15 Nov 2025 09:45

Alkem Laboratories Ltd News Hub

News

Alkem Laboratories announces resignation of senior management personnel

Alkem Laboratories announced that Rakesh Tripathi, a Senior Management Personnel has tende...

Read more

08 Dec 2025 11:33

News

Alkem Laboratories announces appointment of senior management personnel

Alkem Laboratories announced that Prakash Ramnani has been appointed at senior management ...

Read more

05 Dec 2025 19:02

News

Alkem Laboratories introduces DSS Probiotic in India to boost gut health

Developed by Prof. Claudio De Simone, DSS combines eight carefully selected bacterial stra...

Read more

21 Nov 2025 11:47

News

Alkem Laboratories Ltd gains for fifth session

Alkem Laboratories Ltd is up for a fifth straight session in a row. The stock is quoting a...

Read more

13 Nov 2025 13:00

News

Alkem Laboratories' CSR arm announces strategic collaboration with IIT Bombay

 Alkem Foundation, the Corporate Social Responsibility (CSR) arm of Alkem Laboratories (Al...

Read more

03 Nov 2025 19:10

News

Alkem Laboratories declare Quarterly Result

Alkem Laboratories will hold a meeting of the Board of Directors of the Company on 13 Nove...

Read more

24 Oct 2025 10:03

SWOT Analysis Of Alkem Laboratories Ltd

Strength

3

S

Weakness

3

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Alembic Pharmaceuticals Ltd

Strength

1

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Alkem Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Alembic Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Alembic Pharmaceuticals Ltd and Alkem Laboratories Ltd

Which company has a larger market capitalization, Alembic Pharmaceuticals Ltd or Alkem Laboratories Ltd?

Market cap of Alembic Pharmaceuticals Ltd is 16,646 Cr while Market cap of Alkem Laboratories Ltd is 67,284 Cr

What are the key factors driving the stock performance of Alembic Pharmaceuticals Ltd and Alkem Laboratories Ltd?

The stock performance of Alembic Pharmaceuticals Ltd and Alkem Laboratories Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Alembic Pharmaceuticals Ltd and Alkem Laboratories Ltd?

As of December 18, 2025, the Alembic Pharmaceuticals Ltd stock price is INR ₹846.9. On the other hand, Alkem Laboratories Ltd stock price is INR ₹5627.4.

How do dividend payouts of Alembic Pharmaceuticals Ltd and Alkem Laboratories Ltd compare?

To compare the dividend payouts of Alembic Pharmaceuticals Ltd and Alkem Laboratories Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions